Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Treasury Shares (2023 - 2025)

Profound Medical (PROF) has 3 years of Treasury Shares data on record, last reported at $859335.0 in Q4 2025.

  • For Q4 2025, Treasury Shares rose 164.72% year-over-year to $859335.0; the TTM value through Dec 2025 reached $859335.0, up 164.72%, while the annual FY2025 figure was $859335.0, 164.72% up from the prior year.
  • Treasury Shares reached $859335.0 in Q4 2025 per PROF's latest filing, up from $143820.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $1.1 million in Q2 2025 and bottomed at $91670.0 in Q1 2025.
  • Average Treasury Shares over 3 years is $498049.3, with a median of $409008.5 recorded in 2023.
  • Peak YoY movement for Treasury Shares: plummeted 34.21% in 2024, then soared 164.72% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $493396.0 in 2023, then tumbled by 34.21% to $324621.0 in 2024, then surged by 164.72% to $859335.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $859335.0 in Q4 2025, $143820.0 in Q3 2025, and $1.1 million in Q2 2025.